Browsing by Subject "conversion disorder"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Prevalence of pseudoneurologic conversion disorder in an urban community in Manisa, Turkey
    (2007) Deveci A.; Taskin O.; Dinc G.; Yilmaz H.; Demet M.M.; Erbay-Dundar P.; Kaya E.; Ozmen E.
    Background: There is not a wide agreement upon rate of conversion disorder within Turkish population. The aim of this study was to determine the prevalence of conversion disorder with pseudoneurological symptoms or deficits and related risk factors in a city. Method: In total, 1,086 people, aged 15-65 years old, were selected from the city of Manisa, Turkey to take part in the study. We applied sociodemographic and health information questionnaires and the Composite International Diagnostic Interview (CIDI) Somatization Subscales to the samples. Results: The likelihood that an individual might have conversion disorder with pseudoneurological symptoms or deficits was found to be 5.6% (n = 61). The prevalence of conversion disorder with pseudoneurological symptoms or deficits was significantly higher among women (p < 0.0001), 15-24 year old women (p = 0.011) and 25-34 year old women (p = 0.003), people who live as squatters (p = 0.03), those with a history of psychiatric disorder (p < 0.0001) and those having a mother with a psychiatric disorder (p = 0.04). Conclusion: This study has shown the conversion disorder with pseudoneurological symptoms or deficits is inadequately frequent in the population. © Springer-Verlag 2007.
  • No Thumbnail Available
    Item
    Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression
    (2007) Deveci A.; Aydemir O.; Taskin O.; Taneli F.; Esen-Danaci A.
    The aim of the present study was to compare serum brain-derived neurotrophic factor (BDNF) levels of patients with major depressive disorder (MDD) and conversion disorder (CD). Serum BDNF levels were measured in the following three groups: 15 CD patients without any comorbid diagnosis of psychiatric disorder, 24 patients with MDD, and 26 healthy subjects without any psychiatric diagnosis or psychiatric treatment. The serum BDNF level of the healthy control group (31.4 ± 8.8 ng/mL) was statistically higher than the level of the MDD group (21.2 ± 11.3 ng/mL) and the CD group (24.3 ± 9.0 ng/mL; P = 0.008). This suggests that BDNF level may play a similar role in the pathophysiology of MDD and CD. © 2007 The Authors.